相关实验视频

Updated: May 3, 2026

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species

Published on: February 27, 2018

通过HTT-LC3链接化合物选择性降低突变HTT蛋白

Zhaoyang Li¹, Cen Wang¹, Ziying Wang¹

¹Neurology Department at Huashan Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institutes of Brain Science, School of Life Sciences, Fudan University, Shanghai, China.

|November 1, 2019

概括

研究人员确定了通过自来清除突变狩猎蛋白的化合物. 这些化合物有望治疗亨廷顿病

科学领域:

神经科学
分子生物学
药物发现

背景情况:

蛋白质聚合,特别是突变蛋白质,是众多被称为蛋白质病的基础.
亨廷顿病是一种神经退行性疾病,由突变的亨廷丁蛋白 (mHTT) 和扩大的多重胺 (polyQ) 通道引起.
降低引起疾病的蛋白质水平是蛋白质病的治疗策略.

研究的目的:

确定可以针对mHTT进行自清除的化合物.
调查与微管相关蛋白1A/1B轻链3 (LC3) 和mHTT结合的化合物是否可以降低mHTT水平并拯救疾病表型.
探索这些化合物对抗其他多Q扩张疾病的潜力,例如由突变性ATAXIN-3 (ATXN3) 引起的疾病.

主要方法:

使用基于小分子微阵列的选来识别化合物.
化合物与LC3和mHTT进行了相互作用测试,但没有野生型HTT.
对亨廷顿病的细胞和体内 (和小鼠) 模型进行了测试.

主要成果:

确定了与LC3和mHTT结合的四种化合物.
这些化合物成功地将mHTT向自细胞,导致mHTT水平的等位素选择性降低.
在细胞和动物模型中挽救了与疾病相关的表型;化合物还降低了突变ATXN3水平.

结论:

这项研究提出了能够向mHTT自降解的新型化合物.
这种方法证明了自细胞结合化合物的治疗亨廷顿病和其他多Q扩张障碍的潜力.
这些已识别的化合物代表了由扩展的多Q蛋白驱动的蛋白质病变的有前途的治疗候选物.

更多相关视频

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy

Published on: June 27, 2018

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Published on: December 10, 2021

相关概念视频

Huntington Disease l: Introduction

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...